---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-25-000337"
form_type: "8-K"
ticker: "SNTI"
cik: "0001854270"
company_name: "Senti Biosciences, Inc."
filed_at: "2025-01-06T23:59:59+00:00"
generated_at: "2026-05-28T11:27:26.147305+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Senti Bio secures additional $11.5M from PIPE closing and CIRM grant; cash runway into 2026

## Summary
- Closed subsequent PIPE closing with Celadon Partners for additional ~$10M gross proceeds (4,444 Series A shares + warrants for 6,666,000 common shares); total PIPE now $47.6M.
- Received $1.5M from CIRM grant; total received $6.4M of $8M grant announced June 2024.
- Cash runway guidance extended into 2026; proceeds to fund SENTI-202 development and manufacturing.
- Securities sold under Section 4(a)(2)/Rule 506 exemption; registration rights agreement for resale filed.

## SEC filing metadata
- accession: 0001140361-25-000337
- form_type: 8-K
- ticker: SNTI
- cik: 0001854270
- company_name: Senti Biosciences, Inc.
- filed_at: 2025-01-06T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.03, 8.01, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1854270/000114036125000337/0001140361-25-000337-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1854270/000114036125000337/ef20040800_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-25-000337
- JSON: https://secwatch.observer/filing/0001140361-25-000337.json
- Plain text: https://secwatch.observer/filing/0001140361-25-000337.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.